Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132950) titled 'Rupatadine Tablets for the Treatment of Refractory Urticaria: Clinical Characteristics, Treatment Response, and Predictive Indicators' on Sept. 20.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Army Medical University
Condition:
Refractory urticaria (urticarial wheals or itching persisting despite treatment with double-dose antihistamines)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-11-01
Target Sample Size: Observation group:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org...